As part of its patient care mission, Bridgeport Hospital participates in a number of clinical research studies aimed at improving treatment for patients.
State cancer registries enable public health professionals to better understand and address cancer burden. Registry data are critical for targeting programs focused on risk-related behaviors or on environmental risk factors. Such information is also essential for identifying when and where cancer screening efforts should be enhanced and for monitoring the treatment provided to cancer patients. In addition, reliable registry data are fundamental to a variety of research efforts, including those aimed at evaluating the effectiveness of cancer prevention, control or treatment programs. In the United States, these data are reported to a central statewide registry from various medical facilities including hospitals, physicians’ offices, therapeutic radiation facilities, freestanding surgical centers and pathology laboratories. During Fiscal Year 2013, the total cost associated with the Bridgeport Hospital cancer registry was $211,970.
Cancer Clinical Trials
Teaching hospitals like Bridgeport Hospital are where the best and brightest minds in medicine collaborate to provide the highest quality, clinically proven and most technologically advanced care possible. Experienced, pioneering medical practitioners guide the next generation of researchers and healthcare providers in the discovery of new cures and treatments, and offer patients the latest, most effective diagnostic and treatment options before they are available elsewhere. Clinical trials at Bridgeport Hospital and the Yale School of Medicine include Phase Two trials, which tests for efficacy and dosage in several hundred patients, Phase Three trials, which measure the drug or procedure against the best standard treatment, and other types of trials testing the safety of various types of medical equipment. Clinical trials are available in Cancer, Heart and Cardiovascular and Surgery.
The Clinical Trials Cooperative Group Program at Bridgeport Hospital, which is sponsored by the National Cancer Institute (NCI), is designed to promote and support clinical trials of new cancer treatments, explore methods of cancer prevention and early detection, and study quality-of-life issues and rehabilitation during and after treatment. Bridgeport Hospital offers a number of clinical trials at various locations in the community. There are many trials available for the following cancers: Breast Cancer, Colon Cancer, Prostate Cancer, Lung Cancer, Pancreatic Cancer, Kidney Cancer, Ovarian Cancer, Non-Hodgkin’s Lymphoma, Anemia related to Cancer, Radiation Therapy in Breast Cancer, Cryoablation Therapy in Breast Cancer and Supportive Care. The Bridgeport Hospital Norma F. Pfriem Cancer Institute and Breast Care Center through the Bridgeport Hospital Foundation provides funding for the research coordinator and data coordinator annually. Additional grant funding is obtained through the National Institutes of Health.